Poland· PL-100306820
Leverette
A levonorgestrel and ethinylestradiol product containing levonorgestrelum + ethinylestradiolum, registered in Poland by Exeltis Poland Sp. z o.o.. The same ATC class is registered in 12 of our 19 countries.
Checked against URPL (Poland) on
Informational only — not a medical device.
Where it is registered
Levonorgestrel and ethinylestradiol is registered in 12 of 19 countries.
Countries holding a registration under ATC G03AA07 (levonorgestrel and ethinylestradiol), each read from that country’s own register.
- This record: Poland, from URPL (Poland)
- 8 of them publish a price we can compare per daily dose
Levonorgestrel and ethinylestradiol · ATC G03AA07
12 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Denmark
- Finlandprice
- Icelandprice
- Ireland
- Netherlands
- Norwayprice
- Polandprice
- Spainprice
- Switzerlandprice
The record
At a glance
URPL (Poland)- Active substance
- Levonorgestrelum + Ethinylestradiolum
- Manufacturer
- Exeltis Poland Sp. z o.o.
- Country
- Poland (PL)
- ATC code
- G03AA07
- ATC class
- Levonorgestrel and ethinylestradiol
- Reimbursed
- Not published by this register
- Source register
- URPL (Poland)
- Last checked
- September 27, 2026
Packs & prices · 4
- gtin05909991096373
- gtin05909991096380
- gtin05909991096397
- gtin05909991096403
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
494 interactions on record for levonorgestrel and ethinylestradiol.
Graded by severity as the source publishes them — 40 severe. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Levonorgestrel and ethinylestradiol · interactions on record
494 records
- 40 severe
- 372 moderate
- 49 minor
Most severe, free to view
- Tranexamic acidB02AA02severe
- HeminB06AB01severe
- BosentanC02KX01severe
- GriseofulvinD01AA08severe
33 more interactions with mechanism and management, from a commercially licensed source.
Sign in to check- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Same medicine, other countries
Levonorgestrel and ethinylestradiol in 14 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- CzechiaLEVERETTEExeltis Czech s.r.o., Praha
- GermanyAsumate 20Exeltis Germany Gmbh
- SwitzerlandEffilevo 0.10 mg / 0.02 mg, comprimés pelliculésEFFIK SA
- SpainAILEVA 0,1 MG/0,02 MG COMPRIMIDOS RECUBIERTOS CON PELÍCULA EFGLaboratorios Cinfa S.A.
- United KingdomAmbelina 150microgram/30microgram tabletsCrescent Pharma Ltd
- FranceADEPAL, comprimé enrobéPFIZER HOLDING FRANCE
- NetherlandsEthinylestradiol/Levonorgestrel 0,02 mg/0,10 mg Focus, filmomhulde tablettenFocus Care Pharmaceuticals B.V.
- CanadaALESSE 21PFIZER CANADA ULC
Authorised across Europe · EMA
The same active substance is authorised in 24 EEA countries. Names it is sold under:
- Austria · Erlidona, Ethinylestradiol/Levonorgestrel Nextpharma
- Belgium · Eleonor 20, Lavinia
- Bulgaria · Три-Регол
- Czechia · Ebelya, Minisiston
- Germany · Asumate 20, Asumate 30
- Denmark · Anastrella, Femicept
- Spain · Aileva, Anaomi
- France · Adepal, Asterluna
- United Kingdom (Northern Ireland) · Ambelina, Elevin
- Croatia · Adexa
- Hungary · Rigevidon, Seasonique
- Ireland · Leonore, Levonorgestrel/ Ethinylestradiol Renata Pharmaceuticals (Ireland)
- Iceland · Levoethin, Melleva
- Italy · Egogyn, Lasca
- Lithuania · Rigevidon, Tri - Regol
- Luxembourg · Levorichter 30, Lowette
- Latvia · Rigevidon
- Netherlands · Ethinylestradiol/Levonorgestrel Ceres Pharma, Ethinylestradiol/Levonorgestrel Focus
- Norway · Melleva, Microgynon
- Portugal · Effilevo, Etinilestradiol + Levonorgestrel Generis
- Romania · Microgynon, Seasonique
- Sweden · Anastrella, Leverette 21
- Slovenia · Stediril-M
- Slovakia · Ebelya, Seasonique
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of URPL (Poland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/8488b2c1-85f4-480c-ae88-09de7e1062b2 GET /v1/drugs/8488b2c1-85f4-480c-ae88-09de7e1062b2?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Tabletki powlekane",
"source": "urpl",
"strength": "0,15 mg + 0,03 mg",
"packaging": "05909991096373 ¦ Rp ¦ 87647\n28 tabl.\n05909991096380 ¦ Rp ¦ 87648\n84 tabl.\n05909991096397 ¦ Rp ¦ 87649\n168 tabl.\n05909991096403 ¦ Rp ¦ 87650\n364 tabl.",
"substance": "Levonorgestrelum 0,15 mg + Ethinylestradiolum 0.03 mg",
"common_name": "Levonorgestrelum + Ethinylestradiolum",
"pl_product_id": "100306820",
"pozwolenie_nr": "21631",
"auth_procedure": "DCP",
"authorisation_validity": "Bezterminowe"
}See everything about levonorgestrel and ethinylestradiol.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.